Schrodinger Income from Continuous Operations 2019-2025 | SDGR

Schrodinger income from continuous operations from 2019 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Schrodinger Annual Income from Continuous Operations
(Millions of US $)
2024 $-187
2023 $41
2022 $-149
2021 $-101
2020 $-27
2019 $-26
2018 $-28
Schrodinger Quarterly Income from Continuous Operations
(Millions of US $)
2025-03-31 $-60
2024-12-31 $-40
2024-09-30 $-38
2024-06-30 $-54
2024-03-31 $-55
2023-12-31 $-31
2023-09-30 $-62
2023-06-30 $4
2023-03-31 $129
2022-12-31 $-27
2022-09-30 $-40
2022-06-30 $-48
2022-03-31 $-34
2021-12-31 $-31
2021-09-30 $-35
2021-06-30 $-35
2021-03-31 $-1
2020-12-31 $-12
2020-09-30 $3
2020-06-30 $-4
2020-03-31 $-14
2019-12-31 $-7
2019-09-30 $-12
2019-06-30 $-1
2019-03-31 $-6
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.690B $0.208B
Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.738B 59.46
Hims & Hers Health (HIMS) United States $12.987B 134.93
Doximity (DOCS) United States $11.457B 53.04
Tempus AI (TEM) United States $11.228B 0.00
IRhythm Technologies (IRTC) United States $4.298B 0.00
Inspire Medical Systems (INSP) United States $3.880B 60.62
Hinge Health (HNGE) United States $3.671B 0.00
Privia Health (PRVA) United States $2.475B 169.17
Clover Health Investments (CLOV) United States $1.735B 0.00
10x Genomics (TXG) United States $1.677B 0.00
Phreesia (PHR) United States $1.648B 0.00
Enovis (ENOV) United States $1.582B 8.82
Azenta (AZTA) United States $1.578B 73.36
Omnicell (OMCL) United States $1.321B 23.31
Evolent Health (EVH) United States $1.199B 102.10
Claritev (CTEV) United States $0.719B 0.00
Fulgent Genetics (FLGT) United States $0.575B 0.00
Standard BioTools (LAB) United States $0.551B 0.00
Butterfly Network (BFLY) United States $0.532B 0.00
Veradigm (MDRX) United States $0.503B 0.00
Talkspace (TALK) United States $0.438B 131.00
TruBridge (TBRG) United States $0.347B 770.33
Outset Medical (OM) United States $0.345B 0.00
Health Catalyst (HCAT) United States $0.282B 0.00
Nyxoah SA (NYXH) Belgium $0.265B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.241B 0.00
CapsoVision (CV) United States $0.197B 0.00
Zepp Health (ZEPP) Netherlands $0.176B 0.00
KORU Medical Systems (KRMD) United States $0.164B 0.00
Pulmonx (LUNG) United States $0.152B 0.00
American Well (AMWL) United States $0.134B 0.00
MDxHealth SA (MDXH) Belgium $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.115B 0.00
CareCloud (CCLD) United States $0.105B 3.98
Insight Molecular Diagnostics (IMDX) United States $0.086B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.083B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00